Sandoz Fills Pipeline Gap With EirGenix Trastuzumab Deal

 
• By Aidan Fry
  
Pipeline
Sandoz has filled a gap in its biosimilars portfolio by partnering with EirGenix for trastuzumab • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products